Call Us Today! 1.800.928.7496

Industry News

Corporate, industry, pharmaceutical and medical device news announcements, press releases, developments and stories for the interstitial cystitis, bladder pain, pelvic pain communities, including: research studies, clinical trials, FDA approvals, recalls and safety alerts

ICN Founder Jill Osborne Serves on CDMRP Research Panel on Antibiotic Resistant Infections

The Peer Reviewed Medical Research Program (PRMRP) research advocate Jill Heidi Osborne MA recently participated in the evaluation of research applications submitted to the PRMRP sponsored by the US Department of Defense. Ms. Osborne has served as a consumer reviewer for the past six years. As a consumer reviewer, she was a full voting member [...]

By |2018-01-02T15:20:04-08:00December 21st, 2017|ICN Announcements, Industry News, Our Blog, Research|Comments Off on ICN Founder Jill Osborne Serves on CDMRP Research Panel on Antibiotic Resistant Infections
Read More

CUA IC/BPS Guidelines Finally Adopted – Canadian Patients Get Much Needed Guidance

CUA IC/BPS Guidelines Adopted Why have so many interstitial cystitis patients in Canada come to the USA for care? Despite the glowing reviews about universal health care, there is a sad IC truth behind the scenes north of the border. There is no national IC organization to advocate on their behalf. Only a handful of physicians in [...]

By |2017-01-20T16:34:08-08:00December 7th, 2016|Awareness, Diagnosis, ICN Announcements, Industry News, News, Our Blog, Research, Treatments|Comments Off on CUA IC/BPS Guidelines Finally Adopted – Canadian Patients Get Much Needed Guidance
Read More

Orphan Drug Status for Pentosan May Deter Lower Price Generics

Bene Arzneimittel GmBH, a german pharmaceutical company, announced in late December 2015 that Pentosan polysulphate (aka Elmiron) has been officially registered as an orphan drug for the treatment of interstitial cystitis by the European Medicines Agency, EMA. "Receiving orphan drug status for pentosan polysulphate in the European Union is a great success for bene", says [...]

By |2017-01-31T08:58:00-08:00January 8th, 2016|Industry News, News, Our Blog|Comments Off on Orphan Drug Status for Pentosan May Deter Lower Price Generics
Read More

Dr. Robert Echenberg, International Pelvic Pain Expert, Expands Clinic To NYC

Dr. Robert Echenberg, one of the top pelvic pain specialists in the world, has announced that he is expanding his practice to New York City effective December 1st, 2015. He will be seeing patients two days a week in NYC and one day a week in his clinic in Pennsylvania. Known for both his patient compassion [...]

By |2017-01-31T09:08:24-08:00November 24th, 2015|ICN Announcements, Industry News, News, Our Blog, Pelvic Pain|Comments Off on Dr. Robert Echenberg, International Pelvic Pain Expert, Expands Clinic To NYC
Read More

Uk Approves Gepan For Home Use – A Chondroitin Bladder Instillation

Gepan instill, a potential treatment for cystitis and overactive bladder, has been added to the Drug Tariff effective October 1, 2015! This means that people with chronic cystitis and overactive bladder syndrome can now easily treat themselves in the comfort and convenience of their own homes rather than having to go to hospital clinics. This [...]

By |2015-10-17T17:08:26-07:00October 17th, 2015|Industry News, News, Our Blog|Comments Off on Uk Approves Gepan For Home Use – A Chondroitin Bladder Instillation
Read More

Introducing Hep-Lido-A Bladder Instillation For Interstitial Cystitis

The most popular and some would argue effective bladder instillation treatment on the market today for interstitial cystitis is heparin and lidocaine. Heparin acts as a soothing bladder coating while lidocaine numbs the nerves in the bladder wall. As a result, many patients walk out of their urologists office feeling dramatically better. Granted, it may [...]

By |2017-01-31T10:32:25-08:00April 28th, 2015|Industry News, News, Our Blog|Comments Off on Introducing Hep-Lido-A Bladder Instillation For Interstitial Cystitis
Read More

New IC Treatments Use Liposomes To Deliver BotoxA Into The Bladder

By Jill Heidi Osborne MA Very interesting Botox study crossed my desk today. As you probably know, Botox A has been used for the treatment of various bladder conditions for several years now. Though it's not approved specifically for the treatment of interstitial cystitis, it is a STEP FOUR treatment option in the AUA's IC/BPS [...]

By |2017-01-31T10:44:58-08:00December 15th, 2014|Industry News, News, Our Blog, Research, Treatments|Comments Off on New IC Treatments Use Liposomes To Deliver BotoxA Into The Bladder
Read More

Interstitial Cystitis Treatment Guidelines Updated by AUA in Fall 2014

The American Urological Association (AUA) released a new update to their 2011 Guideline on the Diagnosis and Treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). The original guidelines included research studies up through 2009. This new revision includes research studies through 2013. Read the amended guidelines here! “Although the science relevant to IC/BPS is continually improving [...]

By |2017-01-31T10:56:23-08:00October 21st, 2014|Industry News, Interstitial Cystitis IC/BPS, News, Our Blog, Pelvic Floor Dysfunction|Comments Off on Interstitial Cystitis Treatment Guidelines Updated by AUA in Fall 2014
Read More

Great New IC Book Released – The Proactive Patient: Managing IC/BPS and Related Conditions by Gaye and Andrew Sandler

Gaye & Andrew Sandler have released their first new book in a decade for men, women & children struggling with IC and its many related conditions. What sets this husband and wife team apart from so many other authors who have written about interstitial cystitis is their focus on patient comfort. In The Proactive Patient: Managing [...]

By |2017-01-31T12:37:49-08:00August 4th, 2014|Awareness, ICN Shop & Mail Order Center, Industry News, Interstitial Cystitis IC/BPS, Jill's Journal, News, Our Blog, Pelvic Floor Dysfunction, Self-Help Tips for IC, Bladder & Pelvic Pain|Comments Off on Great New IC Book Released – The Proactive Patient: Managing IC/BPS and Related Conditions by Gaye and Andrew Sandler
Read More

New Bladder Pain Treatment In Development – IC Clinical Trial

The Interstitial Cystitis Network is pleased to inform you that a research study is now enrolling women between the ages of 18 and 75 who have IC/BPS. This study will assess the effectiveness of an oral investigational study medicine (AQX-1125) to see if it will reduce the moderate to severe IC/BPS pain being experienced by [...]

By |2017-01-31T12:39:07-08:00July 22nd, 2014|Clinical Trials, Industry News, Our Blog, Research|Comments Off on New Bladder Pain Treatment In Development – IC Clinical Trial
Read More
Go to Top